Bipolar Disorder
Bipolar Disorder screening by GIA®, powered by digitalhumanOS™, uses Voice AI, Computer Vision, and Speech Biomarkers to detect bipolar disorder through a single patient conversation. Screening performance: AUC 0.726. Screening takes 40 seconds with results in under 2 minutes.
Unmanaged bipolar disorder disrupts lives and complicates recovery, impacting families and communities.
Bipolar disorder can significantly impact patient compliance and progress in post-acute care. Early screening allows for timely intervention and mood stabilization.
Key Facts
- Screening Time
- 40 seconds
- Results
- under 2 minutes
- Modalities
- Voice + Vision + Speech
- Validation
- Peer-Reviewed (19 studies)
- Status
- Live
This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
About Bipolar Disorder screening.
How does the AI screen for bipolar disorder?
The AI analyzes speech patterns, vocal characteristics, and behavioral cues associated with mood fluctuations.
What are the benefits of identifying bipolar disorder early?
Early identification allows for appropriate medication management and therapeutic interventions, improving mood stability.
What is the accuracy rate for the bipolar disorder screening?
The model achieves an accuracy rate of 72.6%.
The science behind Bipolar Disorder screening.
A 2003 survey of 600 individuals with bipolar disorder conducted through the National Depressive and Manic-Depressive Association (Hirschfeld, Lewis, Vornik, Journal of Clinical Psychiatry) found that 69% reported being misdiagnosed, most commonly with unipolar depression. Misdiagnosed individuals consulted a mean of 4 physicians prior to correct diagnosis, and over one third waited 10 years or more.
Perceptions and Impact of Bipolar Disorder: How Far Have We Really Come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of Individuals with Bipolar Disorder — Journal of Clinical Psychiatry (2003-02)Internal model performance report (v0.2.0, May 2026) from a confidential strategic clinical-validation partner. Reported AUC values (with sensitivity and specificity): depression 0.874 (Sens 0.722, Spec 0.866); anxiety 0.884 (Sens 0.764, Spec 0.850); PTSD 0.907 (Sens 0.888, Spec 0.745); acute stress and nervousness 0.910 (Sens 0.780, Spec 0.891); psychoactive substance use 0.845 (Sens 0.718, Spec 0.806); fatigue and malaise 0.827 (Sens 0.734, Spec 0.910); ADHD 0.848 (Sens 0.634, Spec 0.868); sleep disorders 0.823 (Sens 0.661, Spec 0.831); bipolar disorder 0.726 (Sens 0.444, Spec 0.860). Partner identity withheld per partnership agreement. Operator-confirmed 2026-05-21.
Internal multi-condition model performance report (v0.2.0) (2026-05)View all peer-reviewed research. See how GIA® screens for Bipolar Disorder across care settings.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.